TNF-α-Producing Cryptococcus neoformans Exerts Protective Effects on Host Defenses in Murine Pulmonary Cryptococcosis

Area of Science:

• Immunology
• Mycology
• Infectious Diseases

Background:

• Tumor necrosis factor alpha (TNF-α) is crucial for controlling Cryptococcal infections.
• Insufficient TNF-α leads to persistent Cryptococcus neoformans.
• Therapeutic strategies to boost host anti-fungal responses are needed.

Purpose of the Study:

• To engineer a Cryptococcus neoformans strain that produces murine TNF-α.
• To evaluate the therapeutic potential of TNF-α-producing C. neoformans in a murine model of pulmonary cryptococcosis.

Main Methods:

• Engineered a C. neoformans strain to express murine TNF-α.
• Infected mice with either the engineered or wild-type C. neoformans strain.
• Assessed host immune responses, including T-cell accumulation, cytokine balance, and macrophage activity.
• Evaluated fungal burden and animal survival.

Main Results:

• TNF-α-producing C. neoformans enhanced T-cell accumulation and Th1/Th2 cytokine balance.
• Reduced pulmonary eosinophilia and alternative macrophage activation were observed.
• In vitro studies showed enhanced macrophage fungicidal activity.
• Mice infected with TNF-α-producing C. neoformans exhibited improved fungal control and prolonged survival, but not sterilizing immunity.

Conclusions:

• Engineered TNF-α expression by C. neoformans enhances protective host responses against cryptococcosis.
• This strategy improves fungal control and survival but does not induce complete immune protection.
• Further research into TNF-α-based therapies for cryptococcal infections is warranted.